𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib

✍ Scribed by Scott Goulden; Frances Sutcliffe; Andrew Stevens


Book ID
117785950
Publisher
The Lancet
Year
2012
Tongue
English
Weight
47 KB
Volume
13
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.